Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
Open Access
- 8 April 1999
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (14), 1063-1070
- https://doi.org/10.1056/nejm199904083401402
Abstract
The intraocular ganciclovir implant is effective for local treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome (AIDS), but it does not treat or prevent other systemic manifestations of cytomegalovirus infection.This publication has 36 references indexed in Scilit:
- Sexual Transmission and the Natural History of Human Herpesvirus 8 InfectionNew England Journal of Medicine, 1998
- KSHV and Kaposi's Sarcoma: The End of the Beginning?Cell, 1997
- In vitro antiviral drug sensitivity of the Kaposiʼs sarcoma-associated herpesvirusAIDS, 1997
- Treatment of Cytomegalovirus Retinitis with a Sustained-Release Ganciclovir ImplantNew England Journal of Medicine, 1997
- The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative womenJAMA, 1997
- Kaposiʼs sarcoma-associated herpesvirus infection prior to onset of Kaposiʼs sarcomaAIDS, 1996
- Intravitreous and Plasma Concentrations of Ganciclovir and Foscarnet after Intravenous Therapy in Patients with AIDS and Cytomegalovirus RetinitisThe Journal of Infectious Diseases, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Intravitreal Ganciclovir Concentration after Intravenous Administration in AIDS Patients with Cytomegalovirus Retinitis: Implications for TherapyThe Journal of Infectious Diseases, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958